0001213900-21-031126.txt : 20210607 0001213900-21-031126.hdr.sgml : 20210607 20210607064329 ACCESSION NUMBER: 0001213900-21-031126 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210528 FILED AS OF DATE: 20210607 DATE AS OF CHANGE: 20210607 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RASTER INVESTMENTS, Inc CENTRAL INDEX KEY: 0001858697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54933 FILM NUMBER: 21998168 BUSINESS ADDRESS: STREET 1: 2384 ORCHARD CREST BLVD CITY: MANASQUAN STATE: NJ ZIP: 08736 BUSINESS PHONE: 732-938-6600 MAIL ADDRESS: STREET 1: 2384 ORCHARD CREST BLVD CITY: MANASQUAN STATE: NJ ZIP: 08736 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Immune Therapeutics, Inc. CENTRAL INDEX KEY: 0001559356 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 593226705 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2431 ALOMA AVE #124 CITY: WINTER PARK STATE: FL ZIP: 32792 BUSINESS PHONE: (888) 613-8802 MAIL ADDRESS: STREET 1: 2431 ALOMA AVE #124 CITY: WINTER PARK STATE: FL ZIP: 32792 FORMER COMPANY: FORMER CONFORMED NAME: TNI BIOTECH, INC. DATE OF NAME CHANGE: 20121001 3 1 ownership.xml X0206 3 2021-05-28 0 0001559356 Immune Therapeutics, Inc. IMUN 0001858697 RASTER INVESTMENTS, Inc 2384 ORCHARD CREST BLVD MANASQUAN, NJ 08736 0 0 0 1 Member of 10% owner group Common Stock 5650 D Warrants (Right to Buy) 5.00 2018-12-31 2023-12-30 Common Stock 12000 D Warrants (Right to Buy) 5.00 2019-05-31 2024-05-29 Common Stock 8000 D According to the Annual Report on Form 10-K filed on April 15, 2021 (the "Form 10-K") by the issuer, Immune Therapeutics, Inc. (the "Company"), a reverse stock split of the Company's issued and outstanding, but not authorized, common stock at a ratio of 1,000-to-1 (the "Reverse Split") was approved by the Company's shareholders. The Reverse Split is currently pending approval by the Financial Industry Regulatory Authority, Inc. The information contained in the Form 10-K relating to the shares of Common Stock outstanding and beneficially owned is based on the implementation of the Reverse Split. The information presented herein is likewise based on the implementation of the Reverse Split. The beneficial ownership information presented in this Form 3 is otherwise based on the beneficial ownership of the Reporting Persons as of the date of the event requiring filing of this Form 3. /s/ Raster Investments, Inc.; By Marie Elena Teraskiewicz, Director 2021-05-28